Healthcare stocks declined on Wall Street so far on Thursday, down 0.2%. More broadly, the Dow Jones Industrial Average pushed 0.2% higher, the Nasdaq climbed 0.2% and the S&P 500 was up 0.2%. Some of the biggest gainers among healthcare …
Investor Place · 10 hours ago
Healthcare Stocks
Investors in Astrazeneca plc (NYSE: AZN) saw new options become available today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN options chain for the …
Forbes · 11 hours ago
In-depth coverage >
AstraZeneca plc (LON:AZN)‘s stock had its “buy” rating reissued by equities researchers at Jefferies Group in a research report issued on Thursday, Marketbeat reports. They currently have a GBX 5,600 ($87.88) price target on the biopharmaceutical ...
Ticker Report · 16 hours ago
AstraZeneca plc
More from Bing News
With interest rates set to stay low over the medium term, dividend stocks are likely to remain an important part of Foolish portfolios for many years to come. After all, the return on cash balances is low and may move lower if further stimulus is required ...
Motley Fool UK · 15 minutes ago
Dividend Stocks
Below are the dividend stocks that were subject to analyst moves before the bell. Our analysts weigh in with insight and commentary as to what you can expect going forward. Berenberg upgraded AstraZeneca (AZN) …
Dividend · 12 hours ago
Serco’s stock was extending gains on Wednesday after a well-received ... and amortization basis from 16.8% to 20.8%. Berenberg upgraded AstraZeneca to ‘buy’ from ‘hold’ and raised the price target to 5,200p from 4,800p, saying that Oncology ...
IFA Magazine · 12 hours ago
Smiths Group
Shares of AstraZeneca Pharma India Limited were trading higher by 7% at Rs. 1,247. The stock has hit a high of Rs. 1,278 and a low of Rs. 1,167 on BSE today. The company has announced the launch of FORXIGA - a …
India Infoline Ltd · 6/23/2015
AstraZeneca Pharma stock - Berenberg Bank has upgraded its rating on drugs giant AstraZeneca [LON:AZN] to buy from hold, stating that post-2017 growth is becoming increasingly underappreciated. The broker also pointed out that the shares are not far off 12 ...
Stock Market Wire · 13 hours ago
shares of AstraZeneca have traded between the current low of $63.34 and a high of $76.57 and are now at $63.52. The 200-day and 50-day moving averages have moved 0.18% lower and 0.55% lower over the past week, respectively. One of today's stocks
Financial News Network Online · ByPeter Chu · 6/30/2015
AstraZeneca plc (NYSE:AZN) has been given an “AA-” credit rating by Morningstar. The research firm’s “AA-” rating indicates that the company is a very-low default risk. They also gave their stock a three star rating. Other equities research ...
Mideast Times · 6/23/2015


AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom…
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2012 prescription drug sales and has operations in over 100 countries.
Data from: Wikipedia